CSE's Barrington Miller is joined by Anthony Durkacz, Interim CEO of FSD Pharma (CSE:HUGE) to discuss the company's recent history and transition from the cannabis-era to new opportunities in the growing psychedelics space.
Here's an overview of what Barrington and Anthony discuss in this edition of the "Exchange for Entrepreneurs" podcast:
0:00 - Introducing Anthony Durkacz, Interim CEO of FSD Pharma
5:45 - Working back towards a 1Bn market cap
8:10 - The latest investment in Lucid Psycheceuticals Inc. and treating MS
10:50 - The psychedelics movement
14:13 - Listing on NASDAQ
Subscribe for more great CSE insights and interviews here: https://go.thecse.com/CSETV-Subscribe
STAY CONNECTED WITH THE CSE
=============================
- PODCAST: https://blog.thecse.com/cse-podcasts/
- INSTAGRAM: https://www.instagram.com/canadianexchange/
- LINKEDIN: https://ca.linkedin.com/company/canadian-securities-exchange
- FACEBOOK: https://www.facebook.com/CanadianSecuritiesExchange/
- TWITTER: https://twitter.com/CSE_News
- BLOG: https://blog.thecse.com/
- WEBSITE: https://thecse.com/
Subscribe for more great CSE insights and interviews here: https://go.thecse.com/CSETV-Subscribe
The CSE Podcast
